Status:

UNKNOWN

Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections

Lead Sponsor:

Catholic University of the Sacred Heart

Collaborating Sponsors:

3M

Fondazione C.N.R./Regione Toscana "G. Monasterio", Pisa, Italy

Conditions:

Catheterization

Infection

Eligibility:

All Genders

18+ years

Phase:

PHASE4

Brief Summary

TegaCHG is a multicentric randomized study aimed at evaluating the possibility that the use of TegaDerm CHG dressing may reduce the incidence of catheter related blood stream infections (CRBSI). It im...

Eligibility Criteria

Inclusion

  • Age ≥ 18 years
  • Hospitalized patients, either in Intensive Care Unit or in non-Intensive Care ward settings
  • Clinical indication for the insertion of a non-tunneled central venous catheter (excluding large bore catheters for dialysis or pheresis) or a PICC

Exclusion

  • Age \< 18 years
  • Inability to obtain an informed consent
  • Actual evidence - or recent history (\< 30 days) - of bloodstream infection
  • Central lines inserted in the femoral vein
  • Central lines inserted by surgical cutdown
  • Use of so called 'treated' catheters, i.e. catheters whose internal and/or external surface is coated with antibacterial drugs as well as catheters whose polyurethane releases ions with potential antiseptic action, should be excluded by the present protocol
  • Specific intolerance or known hypersensitivity to transparent dressings or to chlorhexidine
  • Any form of dermatitis, burns, skin lesions or tattoos at the insertion site
  • Burns over ≥ 15% of the body surface area
  • Use of topical antibiotics within a 10cm of the catheter insertion site
  • Enrollment in another investigational drug or device study at any time during this study or 30 days prior.

Key Trial Info

Start Date :

October 1 2009

Trial Type :

INTERVENTIONAL

Allocation :

ESTIMATED

End Date :

October 1 2012

Estimated Enrollment :

1200 Patients enrolled

Trial Details

Trial ID

NCT01142934

Start Date

October 1 2009

End Date

October 1 2012

Last Update

February 1 2012

Active Locations (8)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 2 (8 locations)

1

I.C.U. Ospedale Civico

Palermo, PA, Italy

2

Dpt. Infectious Diseases, Rome Catholic University

Rome, RM, Italy, 00168

3

I.C.U. Rome Catholic University

Rome, RM, Italy, 00168

4

General Surgery Policlinico Umberto I

Rome, RM, Italy

Trial on the Efficacy of Tegaderm Chlorhexidine Gluconate (CHG) in Reducing Catheter Related Bloodstream Infections | DecenTrialz